|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 209/88 | (2006.01) |
| A61K 31/403 | (2006.01) | ||
| A61P 11/06 | (2006.01) |
| (11) | Number of the document | 2558447 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11715042.5 |
| Date of filing the European patent application | 2011-03-21 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-17 |
| (46) | Date of publication of the claims translation | 2015-01-26 |
| (86) | Number | PCT/IB2011/051165 |
| Date | 2011-03-21 |
| (87) | Number | WO 2011/117798 |
| Date | 2011-09-29 |
| (30) | Number | Date | Country code |
| PCT/IB2010/0512 | 2010-03-22 | WO |
| (72) |
AISSAOUI, Hamed, CH
FRETZ, Heinz, CH
HAZEMANN, Julien, CH
RICHARD-BILDSTEIN, Sylvia, CH
SIEGRIST, Romain, CH
|
| (73) |
Idorsia Pharmaceuticals Ltd,
Hegenheimermattweg 91, CH-4123 Allschwil,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 3-(Heteroaril-amino)-1,2,3,4-tetrahidro-9H-karbazolo dariniai ir jų panaudojimas kaip prostaglandino D2 receptoriaus moduliatorių |
| 3-(HETEROARYL-AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2018-02-21 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-03-21 |